I
Market Data
$20.74+$2.51 (+13.77%)
INVA · Last trade
Prev Close
$18.23
Range (29d)
$20.58 – $22.28
Recent Filings
- SC 13G/A13.5 KBInnoviva, Inc.Feb 13, 10:27 AM ET·0001037389-23-000023
- SC 13G/A13.4 KBInnoviva, Inc.Feb 10, 2:11 PM ET·0001306550-23-008575
- SC 13G/A28.4 KBInnoviva, Inc.Feb 1, 7:39 PM ET·0001085146-23-000559
- SC 13G/A13.4 KBInnoviva, Inc.Jan 26, 8:52 AM ET·0001306550-23-004436
- 416.5 KBInnoviva, Inc.Mar 17, 5:16 PM ET·0001567619-21-006518
- SC 13G/A13.5 KBInnoviva, Inc.Jan 26, 6:52 PM ET·0000834237-21-002029
- 8-K83.1 KBInnoviva, Inc.Sep 20, 6:48 AM ET·0001104659-17-057981
- 8-K75.3 KBInnoviva, Inc.Sep 18, 6:58 PM ET·0001104659-17-057707
- 37.4 KBTHERAVANCE INCJul 15, 5:47 PM ET·0001179110-15-011198
- 8-K21.4 KBTHERAVANCE INCMar 20, 7:34 AM ET·0001104659-15-021213
Insiders
10- Aguiar Michael WSr VP, Chief Financial Officer
- BAKER JULIANDirector
- Basso StephenChief Financial Officer
- BLUM LEONARD MSr VP, Chief Comm. Officer
- Brinkley David LHead of Business Dev.
- Campbell Arthur LSr. VP, Technical Operations
- GLICK MARTYExecutive VP, Finance and CFO
- GSK plc10% Owner
- Gunderson Robert V JRDirector
- Humphrey Patrick PAExecutive VP Research
Tickers
Addresses
business
1350 OLD BAYSHORE HIGHWAY SUITE 400
BURLINGAME, CA, 94010
mailing
1350 OLD BAYSHORE HIGHWAY SUITE 400
BURLINGAME, CA, 94010
Former Names
- THERAVANCE INC2015-12-07
- ADVANCED MEDICINE INC2000-08-02